There were six groups including tau-PET− young individuals (~20–25 years old; young/T−), cognitively normal (CN) older adults (CN/T−), and individuals with mild cognitive impairment (MCI) (MCI/T−) and AD dementia (AD/T−). This evidence concerns the gene MAPT and Cognitive impairment.